… Standardization and quality control studies of 'real-time' quantitative reverse transcriptase
polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia…

… Competitive quantitative polymerase chain reaction (QPCR) … Patient monitoring and dose
reductions of imatinib mesylate … This study demonstrates the superior efficacy of imatinib …

… monitoring of the effects of treatment employing sequential … chromosomepositive chronic
myelogenous leukemia with … (1999) “Should polymerase chain reaction analysis to detect …

… a rapid and efficient method for monitoring cytogenetic responses of … in chronic myelogenous
leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. …

… since it has been shown to be superior to interferon-α in regard to its efficacy to induce …
monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low …

… the performance and interpretation of the multivariate competing … monitoring and long‐term
outcomes in chronic myelogenous … using nanofluidic digital polymerase chain reaction assay. …

… by reverse transcriptase polymerase chain reaction (RT-PCR) were initiated more than 30
… in complete cytogenetic remission (CCyR) on interferon alpha [7,8,9,10,11,12]. Competitive …

… Thus, in patients who fail to benefit from ATP-competitive … ) after failure of interferon-alpha
therapy and admitted to our … to be efficient enough to allow specific and reliable monitoring. …

… (allo-SCT) and interferon-alpha (IFNα) have been proven to … transcription polymerase chain
reaction (RT-qPCR) [6,7,8]. … Preservation of quiescent chronic myelogenous leukemia stem …

… study we monitored CML patients treated with imatinib in the chronic phase by RT-PCR.
Samples were collected at diagnosis and then every three months after starting imatinib therapy. …